As of today, there’s $200 million in fresh investment money looking for a new home. But you have to dream big. The funding is meant for companies that “have the potential to generate $100 million a year in revenue.”
So says University City-based 1315 Capital. The growth-equity firm announced Wednesday the closing of a $200 million fund aimed at commercial-stage pharma, medical and healthcare services companies.
An undisclosed group of individual investors, foundations, state and corporate pension funds raised the stately total.
Image: Adele Oliva, 1315 Capital cofounder. (Screenshot via YouTube)
